NICE | May 2020 |COVID-19 rapid guideline: children and young people who are immunocompromised NICE guideline [NG174]
The purpose of this guideline is to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
The guideline covers children and young people (aged 17 and under). It may also be relevant for newborn babies under 72 hours, and 18 to 24 year olds using healthcare services.
Children and young people who are immunocompromised include those with:
- primary immunodeficiencies
- secondary or acquired immunodeficiencies because of their condition
- secondary or acquired immunodeficiencies because of immunosuppressive treatment
- chronic disease associated with immune dysfunction (such as organ dysfunction or failure or severe inflammatory disease).
This guideline focuses on what you need to stop or start doing during the pandemic. Use it alongside your usual professional guidelines, standards and laws (including equalities, safeguarding, communication and mental capacity).
This guideline is for:
- health and care practitioners
- health and care staff involved in planning and delivering services
The recommendations bring together
- existing national and international guidance and policies
- advice from specialists working in the NHS from across the UK. These include people with expertise and experience of treating children and young people who are immunocompromised during the current COVID-19 pandemic.
See NICE for further details